Vitamin D receptor FokI, BsmI, ApaI, and TaqI polymorphisms and susceptibility to ovarian cancer: a meta-analysis
- Authors
- Song, Gwan Gyu; Lee, Young Ho
- Issue Date
- 2013
- Publisher
- INFORMA HEALTHCARE
- Keywords
- Meta-analysis; ovarian cancer; polymorphism; Vitamin D receptor
- Citation
- IMMUNOLOGICAL INVESTIGATIONS, v.42, no.7, pp.661 - 672
- Indexed
- SCIE
SCOPUS
- Journal Title
- IMMUNOLOGICAL INVESTIGATIONS
- Volume
- 42
- Number
- 7
- Start Page
- 661
- End Page
- 672
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/106438
- DOI
- 10.3109/08820139.2013.822881
- ISSN
- 0882-0139
- Abstract
- Objective: The goal of this study was to explore whether vitamin D receptor (VDR) polymorphisms are associated with susceptibility to ovarian cancer. Methods: Meta-analyses were conducted on the associations between the VDR FokI, BsmI, ApaI, and TaqI polymorphisms and ovarian cancer. Results: A total of 12 comparison studies were considered in the meta-analysis, which involved 3716 patients and 5059 controls. Meta-analysis of the VDR FokI polymorphism showed an association between ovarian cancer and the f allele in European populations (OR = 1.094, 95% CI = 1.028-1.163, p = 0.004). Meta-analysis revealed an association between ovarian cancer and the ApaI A allele in all study subjects and Europeans as a sub-group (OR = 1.235, 95% CI = 1.019-1.497, p = 0.032 and OR = 1.287, 95% CI = 1.029-1.609, p = 0.027, respectively). No association was found between ovarian cancer and the BsmI and Taq polymorphisms (OR for B allele = 1.084, 95% CI = 0.936-1.255, p = 0.280, OR for the T allele = OR = 0.847, 95% CI = 0.706-1.270, p = 0.716). Conclusions: This meta-analysis suggests that the VDR FokI and ApaI polymorphisms are associated with susceptibility to ovarian cancer in European populations.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.